Zymeworks Inc (ZYME)
8.55
-0.16
(-1.84%)
USD |
NASDAQ |
Apr 23, 16:00
8.55
0.00 (0.00%)
After-Hours: 20:00
Zymeworks Cash from Financing (TTM): 81.85M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 81.85M |
September 30, 2023 | 30.86M |
June 30, 2023 | 29.59M |
March 31, 2023 | 1.71M |
December 31, 2022 | 108.58M |
September 30, 2022 | 109.65M |
June 30, 2022 | 113.56M |
March 31, 2022 | 114.52M |
December 31, 2021 | 8.011M |
September 30, 2021 | 10.02M |
June 30, 2021 | 8.718M |
March 31, 2021 | 8.252M |
December 31, 2020 | 308.98M |
September 30, 2020 | 308.44M |
June 30, 2020 | 306.19M |
Date | Value |
---|---|
March 31, 2020 | 495.92M |
December 31, 2019 | 193.66M |
September 30, 2019 | 191.36M |
June 30, 2019 | 189.45M |
March 31, 2019 | 91.87M |
December 31, 2018 | 91.43M |
September 30, 2018 | 91.70M |
June 30, 2018 | 92.44M |
March 31, 2018 | 50.10M |
December 31, 2017 | 49.95M |
September 30, 2017 | 48.53M |
June 30, 2017 | 48.46M |
March 31, 2017 | 5.707M |
December 31, 2016 | 64.78M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
1.71M
Minimum
Mar 2023
495.92M
Maximum
Mar 2020
137.86M
Average
109.65M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
Emergent BioSolutions Inc | -535.70M |
MariMed Inc | 22.98M |
Viemed Healthcare Inc | 2.826M |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |